Nexrutine® Reduces Pain,Inflammation

Nexrutine® Reduces Pain,Inflammation

IRVINE, Calif.New researchshows a patent-pending extract of bark from the Phellodendronamurense tree (as Nexrutine®, from NextPharmaceuticals), may help manage pain and inflammation within two weeks. According to the company, the new findings suggest theingredient produces results more rapidly than other supplements marketed foranti-inflammatory effects.

In the new proprietary, open-label study, 280 patients weresupplemented with Nexrutine (up to two 250 mg capsules taken up to three times aday) and asked to fill out a questionnaire on pain. According to the results ofthe trial, Nexrutine reduced pain and/or inflammation and increased mobility andflexibility in 255 (88 percent) of test subjects supplemented. In addition, 88percent of individuals supplemented with Nexrutine said they would recommend thesupplement to others.

For more information, visit www.nextpharmaceuticals.com or Booth #3077 at SupplySide West.